In this task, you're given a paragraph and title from the research paper. Your task is to classify whether the given title is suitable or not for the research paper based on the given paragraph. Return "True" if title is proper according to paragraph else "False".

Example Input: Paragraph: Background: Canine parvovirus 2 (CPV 2) is a major infectious cause of mortality in puppies. The characteristic symptom of CPV 2 disease is intestinal hemorrhage with severe bloody diarrhea. Soon after CPV was first recognized in the late 1970s, the original virus, CPV 2, was replaced in the canine population by strains carrying minor antigenic variants (termed 2a, 2b, and 2c) of the VP2 gene that could be distinguished using monoclonal antibodies and molecular analyses. Here, we provide an updated molecular characterization of the CPV 2 circulating in Taiwan. Methods: In this study, 28 isolates of CPV 2 from 144 dogs with suspected CPV infection were obtained from northern, central, and southern Taiwan from 2008 to 2012 and screened by PCR. The 28 isolates were sequenced, and a phylogenetic analysis of the VP2 gene was performed. Results: Of the 28 Taiwanese CPV 2 isolates, 15 were identified as new CPV 2a, and 13 were identified as new CPV 2b. Compared to the reference CPV 2a, all 15 of the CPV 2a sequences collected in this study contain an Ile324 mutation caused by a TAT to ATT mutation at nucleotides 970-972 of the VP2 gene. Conclusion: Our VP2 sequence data revealed that both types are currently prevalent CPV 2 field strains circulating in Taiwan, and a unique Ile324 VP2 mutation was found in our Taiwanese CPV 2a isolates and recent Asian isolates. CPV 2c was not observed in this study. 
 Title: Genetic characterization of type 2a canine parvoviruses from Taiwan reveals the emergence of an Ile324 mutation in VP2
Example Output: False

Example Input: Paragraph: New assays for the diagnosis of infectious diseases-particularly those that use molecular technologies-will revolutionize infectious diseases practices, but the fulfillment of the promise is several years away. Problems with currently available molecular assays include a lack of knowledge about the extent of microbial nucleic acid in "normal" hosts, concentration of agent material in small volume samples, lack of microbiologist expertise, lack of adequate reimbursement, and difficulty with validation based on conventional methods. Clinicians must appreciate the shortcomings of new technology to use it effectively and appropriately. However, we are realizing tangible progress in our ability to detect new etiological agents; the availability of rapid, accurate diagnostic tests for previously difficult infections; and advances into new, human responsebased paradigms for diagnostic testing. 
 Title: Implications of New Technology for Infectious Diseases Practice
Example Output: True

Example Input: Paragraph: A sthma is the most common chronic respiratory disorder in childhood, affecting about 10% of local children. 1 Asthma exacerbation resulting in hospitalization accounts for a major fraction of the total cost of asthma care in society. 2 Prospective epidemio-logic studies show that up to 80% of childhood asthma exacerbations are associated with viral upper respiratory tract infections (RTIs). 3 Among respiratory viruses, human rhinovirus (HRV) infection preceded as many as 50% of asthma exacerbations in children. 4 Infl uenza viruses also accounted for substantial morbidity (eg, up to 200 annual outpatient visits per 1,000 children) in children with asthma and other chronic medical conditions. 5 Respiratory syncytial virus (RSV) is another major pathogen causing asthma exacerbation. 4 Background: Up to 80% of asthma exacerbations in white children are associated with viral upper respiratory infections. The relative importance of different respiratory pathogens and relevant microbiological data in Asian children are unclear. This study elucidated the epidemiology of respiratory infections in Hong Kong children with asthma exacerbation. Methods: A total of 209 children aged 3-18 years with asthma exacerbations and 77 controls with stable asthma were recruited. The severity of asthma exacerbations was assessed according to Global Initiative for Asthma guideline, and subjects aged 6 years or older performed exhaled nitric oxide and spirometric measurements. Nested multiplex polymerase chain reaction was used to detect 20 different respiratory pathogens. Results: Respiratory pathogens were detected in 105 (51.0%) subjects. The presence of any respiratory pathogen was associated with asthma exacerbation (odds ratio [OR], 2.77; 95% CI, 1.51-5.11; P , .001). Specifi cally, human rhinovirus (HRV) infection was more common among children with asthma exacerbation (OR, 2.38; 95% CI, 1.09-5.32; P 5 .018). All other pathogens or coinfections were not associated with asthmatic attacks. None of these respiratory infections was associated with the severity of asthma exacerbation ( P . .15 for all). During peak HRV season in the winter of 2007 to 2008, this virus was detected in 46.4% of children with asthma exacerbations. Conclusions: Respiratory viral infections are commonly found in children with asthma exacerbation, with HRV being the most important pathogen in our patients. Respiratory viral infection is a triggering factor for asthma exacerbation but does not correlate with its severity. Abbreviations: FeNO 5 fractional exhaled nitric oxide concentration; HBoV 5 human bocavirus; HCoV 5 human coronavirus; HMPV 5 human metapneumovirus; HRV 5 human rhinovirus; ICS 5 inhaled corticosteroid; NPA 5 nasopharyngeal aspirate; OR 5 odds ratio; PCR 5 polymerase chain reaction; RSV 5 respiratory syncytial virus; RTI 5 respiratory tract infection 
 Title: Multiplex Molecular Detection of Respiratory Pathogens in Children With Asthma Exacerbation
Example Output:
True

